US Stock MarketDetailed Quotes
MBOT Microbot Medical
- 0.980
- +0.050+5.41%
Close Nov 22 16:00 ET
- 0.976
- -0.004-0.39%
Post 17:02 ET
16.59MMarket Cap-1240P/E (TTM)
0.989High0.911Low127.69KVolume0.939Open0.930Pre Close122.43KTurnover0.77%Turnover RatioLossP/E (Static)16.93MShares2.35052wk High4.36P/B16.36MFloat Cap0.82052wk Low--Dividend TTM16.69MShs Float323999.370Historical High--Div YieldTTM8.35%Amplitude0.820Historical Low0.958Avg Price1Lot Size
Microbot Medical Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 29.72%3.3M | 8.05%2.51M | -18.33%2.38M | -24.57%10.14M | -27.14%2.35M | -26.77%2.54M | -34.77%2.32M | -8.09%2.92M | 18.31%13.44M | -18.11%3.22M |
| Selling and administrative expenses | 33.05%1.24M | 14.08%1.09M | -6.68%1.22M | -22.65%4.32M | -7.87%1.12M | -38.72%932K | -30.00%959K | -11.43%1.3M | 9.52%5.58M | -22.44%1.22M |
| -General and administrative expense | 33.05%1.24M | 14.08%1.09M | -6.68%1.22M | -22.65%4.32M | -7.87%1.12M | -38.72%932K | -30.00%959K | -11.43%1.3M | 9.52%5.58M | -22.44%1.22M |
| Research and development costs | 27.79%2.06M | 3.81%1.42M | -27.71%1.17M | -26.01%5.72M | -40.02%1.13M | -17.46%1.61M | -37.76%1.37M | -5.22%1.62M | 25.73%7.74M | -16.49%1.88M |
| Other operating expenses | ---- | ---- | ---- | -20.83%95K | ---- | ---- | ---- | ---- | 11.11%120K | ---- |
| Operating profit | -29.72%-3.3M | -8.05%-2.51M | 18.33%-2.38M | 24.57%-10.14M | 27.14%-2.35M | 26.77%-2.54M | 34.77%-2.32M | 8.09%-2.92M | -18.31%-13.44M | 18.11%-3.22M |
| Net non-operating interest income expense | -13.27%85K | 24.32%46K | -80.30%13K | 424.07%283K | 645.45%82K | 1,533.33%98K | -26.00%37K | 607.69%66K | 54K | 11K |
| Non-operating interest income | ---- | 24.32%46K | ---- | 424.07%283K | ---- | ---- | --37K | ---- | --54K | ---- |
| Total other finance cost | 13.27%-85K | ---- | 80.30%-13K | ---- | ---- | -1,533.33%-98K | ---- | -607.69%-66K | ---- | ---- |
| Other net income (expense) | -512.56%-887K | 388.64%215K | ||||||||
| Gain on sale of security | ---- | ---- | ---- | -185.94%-55K | ---- | ---- | ---- | ---- | 173.56%64K | ---- |
| Special income (charges) | ---- | ---- | ---- | -650.99%-832K | ---- | ---- | ---- | ---- | 15.27%151K | ---- |
| -Less:Other special charges | ---- | ---- | ---- | 632.05%830K | ---- | ---- | ---- | ---- | ---156K | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | 60.00%-2K | ---- | ---- | ---- | ---- | ---5K | ---- |
| Income before tax | -31.44%-3.22M | -7.78%-2.47M | 16.89%-2.37M | 18.44%-10.74M | -5.20%-3.15M | 29.47%-2.45M | 34.90%-2.29M | 10.54%-2.85M | -16.40%-13.17M | 22.31%-3M |
| Income tax | ||||||||||
| Net income | -31.44%-3.22M | -7.78%-2.47M | 16.89%-2.37M | 18.44%-10.74M | -5.20%-3.15M | 29.47%-2.45M | 34.90%-2.29M | 10.54%-2.85M | -16.40%-13.17M | 22.31%-3M |
| Net income continuous Operations | -31.44%-3.22M | -7.78%-2.47M | 16.89%-2.37M | 18.44%-10.74M | -5.20%-3.15M | 29.47%-2.45M | 34.90%-2.29M | 10.54%-2.85M | -16.40%-13.17M | 22.31%-3M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -31.44%-3.22M | -7.78%-2.47M | 16.89%-2.37M | 18.44%-10.74M | -5.20%-3.15M | 29.47%-2.45M | 34.90%-2.29M | 10.54%-2.85M | -16.40%-13.17M | 22.31%-3M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -31.44%-3.22M | -7.78%-2.47M | 16.89%-2.37M | 18.44%-10.74M | -5.20%-3.15M | 29.47%-2.45M | 34.90%-2.29M | 10.54%-2.85M | -16.40%-13.17M | 22.31%-3M |
| Basic earnings per share | 4.76%-0.2 | 32.00%-0.17 | 52.78%-0.17 | 41.99%-1.05 | 31.58%-0.26 | 57.14%-0.21 | 48.98%-0.25 | 20.00%-0.36 | -13.84%-1.81 | 29.63%-0.38 |
| Diluted earnings per share | 4.76%-0.2 | 32.00%-0.17 | 52.78%-0.17 | 41.99%-1.05 | 31.58%-0.26 | 57.14%-0.21 | 48.98%-0.25 | 20.00%-0.36 | -13.84%-1.81 | 29.63%-0.38 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data